This conference book is your guide to our annual Benelux Local Champions Conference set to take place on Tuesday, 27 May 2025 at our historic building at Grand Place in Brussels. This event offers the possibility to have one-on-one meetings and/or small group meetings with the following Benelux companies and their top management & IR. ACKERMANS & VAN HAAREN | AGEAS | AHOLD DELHAIZE | AKZONOBEL | ARCADIS | AZELIS | CORBION | GBL | KBC GROUP | LOTUS BAKERIES | MELEXIS | PROXIMUS | SOFINA | UMIC...
ABN AMRO: NFLI reaching c.30% level in its ABN stake reduction. ABN AMRO: Relaunch of Belgium private banking using MeesPierson brand. Elia: FY25 profit outlook unchanged, minor reduction in capex. Greenyard: Disappointing 2H24/25, guidance lowered. NN Group, ASR: Parliament votes against amendment to Dutch Pension Reform
In its 1Q25 trading update, Elia confirmed its FY25 net group profit outlook between EUR 490m and 540m. Elia now uses a lower base rate for the GE regulatory return of 2.30% and 2.80% for ETB. At the FY24 results the Capex FY24-28 was raised by 1.6bn to 31.6bn. 50Hz typically has a higher ROE (8-10%) vs. ETB (7-8%). WindGrid is evaluating Forward Power Offshore, which holds a 25% stake in Leading Light Wind, a project currently facing uncertainty due to executive orders from the Trump Administr...
Aalberts reports the progress of its share buyback programme 12 May – 16 May 2025 Aalberts today reports that it has repurchased 2,500 of its own shares in the period from 12 May 2025, up to and including 16 May 2025, for an amount of EUR 77,447.70, so at an average share price of EUR 30.98. This is part of the share buyback programme as announced on 27 February 2025, for a total amount of EUR 75 million. The repurchase of shares commenced on 28 February 2025 and will be completed no later than 24 October 2025. It is intended that the shares will be cancelled following repurchase. Up to ...
Melexis: update on the share buy-back program Press release - Regulated Information Ieper, Belgium – 19 May 2025, 17.45 hrs CET Further to the initiation of the share buy-back program announced on 10 December 2024, Melexis reports the purchase of 25,124 Melexis shares on Euronext Brussels in the period from 12 to 16 May 2025. Trade dateTotal shares purchasedAverage price (€)Min price (€)Max price (€)Buyback amount (€)12/5/202512458.4958.4558.507,25313/5/20256,00060.6359.8061.20363,76814/5/20256,00060.3259.7561.55361,93715/5/20256,00061.3260.4561.55367,92916/5/20257,00060.9360.6561.70426...
Melexis: update over het aandeleninkoopprogramma Persbericht - Gereglementeerde informatie Ieper, België – 19 mei 2025, 17.45 uur CET Naar aanleiding van het aandeleninkoopprogramma dat op 10 december 2024 werd aangekondigd, maakt Melexis bekend dat er 25.124 eigen aandelen ingekocht werden op Euronext Brussel tussen 12 en 16 mei 2025. InkoopdatumAantal verworven aandelenGemiddelde prijs (€)Laagste prijs (€)Hoogste prijs (€)Aankoop bedrag (€)12/5/202512458,4958,4558,507.25313/5/20256.00060,6359,8061,20363.76814/5/20256.00060,3259,7561,55361.93715/5/20256.00061,3260,4561,55367.92916/5/20...
We updated our model (€ 70 Target Price and Buy rating reiterated) after 1Q25 sales were in line with expectations. Amid more volatile market conditions, Melexis remain fully focused on the things within its control, managing the present and preparing the future. Melexis 1H25 outlook is in line with expectations in spite of the recent weakening of the USD. Melexis expect that they will progressively convert the increased number of new products and design wins into sales. Due to the ongoing inve...
The abstracts for presentations at EHA (12-15 June) became available yesterday during the day (here). While we may have to wait until the actual conference for the latest datasets, here in this note are some key takeaways for our coverage including updates from Autolus (long-term findings and predictors of sustained remission for Aucatzyl in r/r adult ALL, as well as age stratified outcomes), Galapagos (more data and follow up from its decentralised CAR-T program) and MaaT (additional data from ...
Melexis Appoints Two New Directors to Its Board of Directors Tessenderlo-Ham, Belgium – May 15, 2025 Melexis NV (Euronext Brussels: MELE), a global supplier of micro-electronic semiconductor solutions, announces the appointment of two new members to the board of directors following the approval by the annual shareholders’ meeting held on May 13, 2025. The announcement of Ms. Ling Qi and Mr. Kazuhiro Takenaka underlines Melexis’ focused ambitions in the Asia-Pacific Region (APAC). Ms. Ling Qi has more than 20 years of international business management experience. Currently, she is CEO of...
Two Directors at Aalberts NV bought 7,500 shares at between 30.940EUR and 31.100EUR. The significance rating of the trade was 55/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the las...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.